Claussen Christian 4
4 · Arteris, Inc. · Filed Oct 29, 2021
Insider Transaction Report
Form 4
Claussen Christian
Director
Transactions
- Award
Common Stock
2021-10-26+6,250→ 6,250 total - Conversion
Series A Preferred Stock
2021-10-29−3,127,907→ 3,127,907 total(indirect: See Footnote)→ Common Stock (3,127,907 underlying) - Conversion
Common Stock
2021-10-29+3,127,907→ 3,127,907 total(indirect: See Footnote)
Footnotes (4)
- [F1]Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]The reporting person is a General Partner of Ventech Capital F ("Ventech"). Investment and voting decisions for Ventech are made by Ventech's investment committee, which is governed by a non-executive board comprised of three or more individuals, and therefore the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any.
- [F3]Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date.
- [F4]Includes 6,250 restricted stock units.